The Competition Commission has its sights set on Swiss company, Roche, for overpriced breast cancer treatment. It says the company overcharged for the much-needed Trastuzumab drug. The excessive pricing saw over 10,000 patients go without treatment.
It’s alleged this was the case in both the public and private sectors. The price gouging dates all the way back to 2011.
The commission says this is not only a contravention of the Competition Act but is a violation of human rights. It has referred the matter to the Competition Tribunal for a hearing.
Source: eNCA
In other news – Actor Siyabonga Radebe joins Uzalo
Siyabonga Radebe has made a big comeback to the screen as he has finally joined the cast of SABC 1’s popular space Uzalo.
The star won the heart of many in 2006-2009, when he starred as Cassius in the SABC1 drama series A Place Called Home and he never looked back. Learn more
